Profound Medical Future Growth
Future criteria checks 2/6
Profound Medical is forecast to grow earnings and revenue by 41.3% and 44.5% per annum respectively while EPS is expected to grow by 45.9% per annum.
Key information
41.3%
Earnings growth rate
45.9%
EPS growth rate
Medical Equipment earnings growth | 17.6% |
Revenue growth rate | 44.5% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 17 Sep 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 46 | -17 | N/A | -6 | 6 |
12/31/2025 | 27 | -25 | N/A | -16 | 6 |
12/31/2024 | 11 | -29 | N/A | -25 | 6 |
6/30/2024 | 8 | -28 | -23 | -23 | N/A |
3/31/2024 | 7 | -28 | -22 | -22 | N/A |
12/31/2023 | 7 | -29 | -22 | -22 | N/A |
9/30/2023 | 6 | -29 | -22 | -22 | N/A |
6/30/2023 | 7 | -29 | -23 | -23 | N/A |
3/31/2023 | 7 | -27 | -24 | -24 | N/A |
12/31/2022 | 7 | -29 | -26 | -26 | N/A |
9/30/2022 | 6 | -29 | -24 | -24 | N/A |
6/30/2022 | 7 | -30 | -24 | -23 | N/A |
3/31/2022 | 8 | -31 | -24 | -24 | N/A |
12/31/2021 | 7 | -31 | -23 | -22 | N/A |
9/30/2021 | 9 | -28 | -26 | -25 | N/A |
6/30/2021 | 8 | -28 | -25 | -24 | N/A |
3/31/2021 | 7 | -26 | -20 | -20 | N/A |
12/31/2020 | 7 | -22 | -21 | -21 | N/A |
9/30/2020 | 7 | -18 | -19 | -19 | N/A |
6/30/2020 | 5 | -17 | -17 | -17 | N/A |
3/31/2020 | 4 | -16 | -20 | -20 | N/A |
12/31/2019 | 4 | -15 | -15 | -15 | N/A |
9/30/2019 | 3 | -15 | -13 | -13 | N/A |
6/30/2019 | 3 | -14 | -14 | -14 | N/A |
3/31/2019 | 3 | -14 | -13 | -13 | N/A |
12/31/2018 | 2 | -15 | -13 | -13 | N/A |
9/30/2018 | 2 | -16 | -14 | -14 | N/A |
6/30/2018 | 3 | -16 | -12 | -12 | N/A |
3/31/2018 | 4 | -15 | N/A | -11 | N/A |
12/31/2017 | 4 | -15 | N/A | -12 | N/A |
9/30/2017 | 2 | -15 | N/A | -12 | N/A |
6/30/2017 | 1 | -14 | N/A | -12 | N/A |
3/31/2017 | 0 | -12 | N/A | -11 | N/A |
12/31/2016 | N/A | -12 | N/A | -11 | N/A |
9/30/2016 | N/A | -11 | N/A | -9 | N/A |
6/30/2016 | N/A | -10 | N/A | -8 | N/A |
3/31/2016 | N/A | -14 | N/A | -7 | N/A |
12/31/2015 | N/A | -12 | N/A | -5 | N/A |
9/30/2015 | N/A | -12 | N/A | -5 | N/A |
6/30/2015 | N/A | -12 | N/A | -3 | N/A |
3/31/2015 | N/A | -8 | N/A | -2 | N/A |
12/31/2014 | N/A | -7 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PROF is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PROF is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PROF is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PROF's revenue (44.5% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: PROF's revenue (44.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PROF's Return on Equity is forecast to be high in 3 years time